Loading...

Amar Upadhyaya Kishan

Title(s)Assistant Professor-in-Residence, Radiation Oncology
SchoolMedicine
Address200 Medical Plaza Driveway B-265-6
Los Angeles CA 90024
Phone310-825-9771
vCardDownload vCard
    Other Positions
    Title(s)Assistant Professor-in-Residence, Urology


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3,502 patients. Radiother Oncol. 2020 Jul 11. Levin-Epstein R, Cook RR, Wong JK, Stock RG, Jeffrey Demanes D, Collins SP, Aghdam N, Suy S, Mantz C, Katz AJ, Nickols NG, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas ND, Bagshaw H, Buyyounouski MK, Cao M, Mahal BA, Shabsovich D, Dang A, Yuan Y, Rettig MB, Chang AJ, Jackson WC, Spratt DE, Lehrer E, Zaorsky NG, Kupelian PA, Steinberg ML, Horwitz EM, Jiang NY, Kishan AU. PMID: 32663537.
      View in: PubMed   Mentions:    Fields:    
    2. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. Prostate Cancer Prostatic Dis. 2020 Jul 09. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. PMID: 32647353.
      View in: PubMed   Mentions:    Fields:    
    3. PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics. Clin Nucl Med. 2020 Jul; 45(7):e309-e310. Sonni I, Caron J, Kishan AU, Muthusamy VR, Calais J. PMID: 32404709.
      View in: PubMed   Mentions:    Fields:    
    4. Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 Jun 17. Parikh NR, Kishan AU, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, Felix C, Mathis C, Bradley M, Sachdeva A, Wyatt B, Basehart V, Zomorodian N, Lin L, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Elashoff D, Schaue D, Reiter RE, Nickols NG. PMID: 32562839.
      View in: PubMed   Mentions:    Fields:    
    5. Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer. Int J Radiat Oncol Biol Phys. 2020 Jun 13. Parikh NR, Chang EM, Nickols NG, Rettig MB, Raldow AC, Steinberg ML, Koontz BF, Vapiwala N, Deville C, Feng FY, Spratt DE, Reiter RE, Phillips R, Ost P, Tran PT, Kishan AU. PMID: 32544574.
      View in: PubMed   Mentions:    Fields:    
    6. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. Eur Urol. 2020 May 24. Kishan AU, Romero T, Alshalalfa M, Liu Y, Tran PT, Nickols NG, Ye H, Sajed D, Rettig MB, Reiter RE, Garraway IP, Spratt DE, Freedland SJ, Zhao X, Li Z, Deek M, Livingstone J, Mahal BA, Nguyen PL, Feng FY, Den RB, Schaeffer EM, Lotan TL, Karnes RJ, Klein EA, Ross AE, Grogan T, Davicioni E, Elashoff D, Boutros PC, Weidhaas JB. PMID: 32461072.
      View in: PubMed   Mentions:    Fields:    
    7. Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy. Front Oncol. 2020; 10:786. Valle LF, Ruan D, Dang A, Levin-Epstein RG, Patel AP, Weidhaas JB, Nickols NG, Lee PP, Low DA, Qi XS, King CR, Steinberg ML, Kupelian PA, Cao M, Kishan AU. PMID: 32509582.
      View in: PubMed   Mentions:
    8. Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials. J Clin Oncol. 2020 May 12; JCO1903217. Jackson WC, Hartman HE, Dess RT, Birer SR, Soni PD, Hearn JWD, Reichert ZR, Kishan AU, Mahal BA, Zumsteg ZS, Efstathiou JA, Kaffenberger S, Morgan TM, Mehra R, Showalter TN, Krauss DA, Nguyen PL, Schipper MJ, Feng FY, Sandler HM, Hoskin PJ, Roach M, Spratt DE. PMID: 32396488.
      View in: PubMed   Mentions:    Fields:    
    9. Stereotactic Body Radiotherapy for Prostate Cancer. Am J Mens Health. 2020 May-Jun; 14(3):1557988320927241. Parikh NR, Kishan AU. PMID: 32500805.
      View in: PubMed   Mentions:    Fields:    
    10. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials. Radiother Oncol. 2020 Apr 28; 148:235-242. Lehrer EJ, Kishan AU, Yu JB, Trifiletti DM, Showalter TN, Ellis R, Zaorsky NG. PMID: 32505965.
      View in: PubMed   Mentions:    Fields:    
    11. Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning. Radiother Oncol. 2020 Apr 17; 148:181-188. Pan X, Levin-Epstein R, Huang J, Ruan D, King CR, Kishan AU, Steinberg ML, Qi XS. PMID: 32388444.
      View in: PubMed   Mentions:    Fields:    
    12. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer. Front Oncol. 2020; 10:539. Levin-Epstein R, Qiao-Guan G, Juarez JE, Shen Z, Steinberg ML, Ruan D, Valle L, Nickols NG, Kupelian PA, King CR, Cao M, Kishan AU. PMID: 32373529.
      View in: PubMed   Mentions:
    13. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy. Radiother Oncol. 2020 Apr 09; 148:44-50. Yoon S, Cao M, Aghdam N, Shabsovich D, Kahlon S, Ballas L, Collins S, Steinberg ML, Kishan AU. PMID: 32311600.
      View in: PubMed   Mentions:    Fields:    
    14. Prostate Cancer Radiotherapy Recommendations in Response to COVID-19. Adv Radiat Oncol. 2020 Apr 01. Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. PMID: 32292839.
      View in: PubMed   Mentions:
    15. Salvage therapy at biochemical recurrence of prostate cancer. Nat Rev Urol. 2020 04; 17(4):195-196. Zaorsky NG, Kishan AU. PMID: 32051611.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. JAMA Oncol. 2020 Mar 26. Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. PMID: 32215583.
      View in: PubMed   Mentions:    Fields:    
    17. Caught Between a Rock and a Hard Place. Int J Radiat Oncol Biol Phys. 2020 Mar 12. Kishan AU, Reiter RE. PMID: 32173187.
      View in: PubMed   Mentions:    Fields:    
    18. A novel anthropomorphic multimodality phantom for MRI-based radiotherapy quality assurance testing. Med Phys. 2020 Apr; 47(4):1443-1451. Singhrao K, Fu J, Wu HH, Hu P, Kishan AU, Chin RK, Lewis JH. PMID: 31954078.
      View in: PubMed   Mentions:    Fields:    
    19. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation. Phys Med Biol. 2020 02 05; 65(3):035015. Singhrao K, Ruan D, Fu J, Gao Y, Chee G, Yang Y, King C, Hu P, Kishan AU, Lewis JH. PMID: 31881546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study. J Nucl Med. 2020 Jan 10. Sonni I, Eiber M, Fendler WP, Alano RM, Vangala SS, Kishan AU, Nickols N, Rettig MB, Reiter R, Czernin J, Calais J. PMID: 31924715.
      View in: PubMed   Mentions:    Fields:    
    21. Optimal patient selection for stereotactic body radiotherapy. Lancet Oncol. 2019 12; 20(12):e661. Kishan AU, Collins SP, Nickols NG. PMID: 31797787.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 Feb; 77(2):201-208. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. PMID: 31718822.
      View in: PubMed   Mentions: 2     Fields:    
    23. ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. J Am Coll Radiol. 2019 Nov; 16(11S):S399-S416. Purysko AS, Nikolaidis P, Dogra VS, Ganeshan D, Gore JL, Gupta RT, Heilbrun ME, Khatri G, Kishan AU, Lyshchik A, Savage SJ, Smith AD, Wang ZJ, Wolfman DJ, Wong-You-Cheong JJ, Yoo DC, Lockhart ME. PMID: 31685108.
      View in: PubMed   Mentions:    Fields:    
    24. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Adv Radiat Oncol. 2020 May-Jun; 5(3):404-411. Dang AT, Levin-Epstein RG, Shabsovich D, Cao M, King C, Chu FI, Mantz CA, Stephans KL, Reddy CA, Loblaw DA, Cheung P, Scorsetti M, Cozzi L, DeNittis AS, Wang Y, Zaorsky N, Nickols NG, Kupelian PA, Steinberg ML, Kishan AU. PMID: 32529134.
      View in: PubMed   Mentions:
    25. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    26. Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 11 01; 105(3):628-636. Jiang NY, Dang AT, Yuan Y, Chu FI, Shabsovich D, King CR, Collins SP, Aghdam N, Suy S, Mantz CA, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw H, Prionas N, Buyyounouski MK, Jackson WC, Spratt DE, Nickols NG, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31276777.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. JAMA Oncol. 2019 07 01; 5(7):975-983. Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE. PMID: 31120534.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    28. Key considerations when reviewing subsequent primary cancers following radiotherapy. Lancet Oncol. 2019 06; 20(6):e291. Kishan AU, Wang C, Steinberg ML, Spratt DE. PMID: 31162098.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):149-154. Yuan Y, Aghdam N, King CR, Fuller DB, Weng J, Chu FI, Mardirossian G, Patel A, Nickols NG, Kupelian PA, Steinberg ML, Collins SP, Kishan AU. PMID: 31108142.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014). Adv Radiat Oncol. 2019 Oct-Dec; 4(4):738-747. Wang C, Kishan AU, Yu JB, Raldow A, King CR, Iwamoto KS, Chu FI, Steinberg ML, Kupelian PA. PMID: 31673667.
      View in: PubMed   Mentions:
    31. The current state of randomized clinical trial evidence for prostate brachytherapy. Urol Oncol. 2019 09; 37(9):599-610. Dess RT, Soni PD, Jackson WC, Berlin A, Cox BW, Jolly S, Efstathiou JA, Feng FY, Kishan AU, Stish BJ, Pisansky TM, Spratt DE. PMID: 31060795.
      View in: PubMed   Mentions:    Fields:    
    32. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2020 Jan; 77(1):3-10. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 30992160.
      View in: PubMed   Mentions:    Fields:    
    33. Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):778-789. Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, Gharzai LA, Jaworski EM, Mehra R, Hearn JWD, Morgan TM, Salami SS, Cooperberg MR, Mahal BA, Soni PD, Kaffenberger S, Nguyen PL, Desai N, Feng FY, Zumsteg ZS, Spratt DE. PMID: 30959121.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    34. Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial. Br J Radiol. 2019 Jul; 92(1099):20181001. Kishan AU, Tyran M, Weng J, Upadhyaya S, Lamb J, Steinberg M, King C, Cao M. PMID: 30912957.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    35. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. BMC Cancer. 2019 Apr 01; 19(1):291. Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG. PMID: 30935383.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    36. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2019 02 01; 2(2):e188006. Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. PMID: 30735235.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2019 Feb 01. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions:    Fields:    
    38. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? Eur Urol. 2019 05; 75(5):e133-e134. Kishan AU, Hall WA, Spratt DE. PMID: 30670312.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis. JAMA Oncol. 2019 01 01; 5(1):91-96. Kishan AU, Wang X, Seiferheld W, Collette L, Sandler KA, Sandler HM, Bolla M, Maingon P, De Reijke T, Hanks GE, Nickols NG, Rettig M, Drakaki A, Reiter RE, Spratt DE, Kupelian PA, Steinberg ML, King CR. PMID: 30326032.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):50-60. Ballas LK, Luo C, Chung E, Kishan AU, Shuryak I, Quinn DI, Dorff T, Jhimlee S, Chiu R, Abreu A, Jennelle R, Aron M, Groshen S. PMID: 30605751.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    41. Treatment of the primary tumor in metastatic prostate cancer. World J Urol. 2019 Dec; 37(12):2597-2606. Yuan Y, Kishan AU, Nickols NG. PMID: 30456709.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8: Setting the Standard: The Importance of Defining the Standard of Care for Comparative Effectiveness Analyses. Eur Urol Oncol. 2019 03; 2(2):224-225. Kishan AU, Cook RR, King CR. PMID: 31017101.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer. Am J Clin Oncol. 2018 09; 41(9):898-904. Shaverdian N, Kishan AU, Veruttipong D, Demanes DJ, Kupelian P, McCloskey S, Steinberg ML, King CR. PMID: 28537990.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer. Am J Clin Oncol. 2018 08; 41(8):739-746. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Kishan AU, Saigal C, Rettig M, Steinberg ML, King CR. PMID: 28301348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Optimal Treatment for High-Risk Prostate Cancer-Reply. JAMA. 2018 07 24; 320(4):405. Kishan AU, Cook RR, King CR. PMID: 30043055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Image-guided radiotherapy for prostate cancer. Transl Androl Urol. 2018 Jun; 7(3):308-320. Dang A, Kupelian PA, Cao M, Agazaryan N, Kishan AU. PMID: 30050792.
      View in: PubMed   Mentions:
    47. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer? Am J Clin Oncol. 2018 06; 41(6):549-557. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Saigal C, Rettig M, Steinberg ML, King CR. PMID: 27560157.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):3-18. Kishan AU, Tendulkar RD, Tran PT, Parker CC, Nguyen PL, Stephenson AJ, Carrie C. PMID: 31100226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer. J Nucl Med. 2018 11; 59(11):1714-1721. Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. PMID: 29653978.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    50. Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer. Cureus. 2018 Apr 06; 10(4):e2442. Hegde JV, Cao M, Yu VY, Kishan AU, Shaverdian N, Lamb J, Steinberg ML. PMID: 29881655.
      View in: PubMed   Mentions:
    51. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):883-888. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 29976500.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer. Cureus. 2018 Mar 22; 10(3):e2360. Kishan AU, Tyran M, Steinberg ML, Holden SB, Cao M. PMID: 29805929.
      View in: PubMed   Mentions:
    53. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA. 2018 03 06; 319(9):896-905. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 29509865.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT. Br J Radiol. 2018 Feb; 91(1083):20170522. Thomas DH, Santhanam A, Kishan AU, Cao M, Lamb J, Min Y, O'Connell D, Yang Y, Agazaryan N, Lee P, Low D. PMID: 29166129.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2018 03; 166:116-123. Nguyen T, Duong C, Sheppard JP, Lee SJ, Kishan AU, Lee P, Tenn S, Chin R, Kaprealian TB, Yang I. PMID: 29414150.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Comparison of lung tumor motion measured using a model-based 4DCT technique and a commercial protocol. Pract Radiat Oncol. 2018 May - Jun; 8(3):e175-e183. O'Connell D, Shaverdian N, Kishan AU, Thomas DH, Dou TH, Lewis JH, Lamb JM, Cao M, Tenn S, Percy LP, Low DA. PMID: 29429921.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning. J Nucl Med. 2018 02; 59(2):230-237. Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. PMID: 29123013.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    58. Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. JCO Clin Cancer Inform. 2017 11; 1:1-6. Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR. PMID: 30657383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Online Adaptive Radiation Therapy: Implementation of a New Process of Care. Cureus. 2017 Aug 27; 9(8):e1618. Lamb J, Cao M, Kishan A, Agazaryan N, Thomas DH, Shaverdian N, Yang Y, Ray S, Low DA, Raldow A, Steinberg ML, Lee P. PMID: 29104835.
      View in: PubMed   Mentions:
    60. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy. Brachytherapy. 2017 Nov - Dec; 16(6):1106-1112. Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M. PMID: 28807747.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease. Br J Radiol. 2017 Aug; 90(1076):20170134. Kishan AU, Voog JC, Wiseman J, Cook RR, Ancukiewicz M, Lee P, Ryan DP, Clark JW, Berger DL, Cusack JC, Wo JY, Hong TS. PMID: 28613934.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer. Urology. 2017 Sep; 107:171-177. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. PMID: 28552819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):1045-1052. Wang C, Kishan AU, Kamrava M, Steinberg ML, King CR. PMID: 28721887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer. Semin Radiat Oncol. 2017 07; 27(3):268-278. Kishan AU, King CR. PMID: 28577834.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. Treatment trends for patients with brain metastases: Does practice reflect the data? Cancer. 2017 Jun 15; 123(12):2274-2282. Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, Steinberg ML, Lee P. PMID: 28178376.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73. Eur Urol. 2017 11; 72(5):e123-e124. Kishan AU, Steinberg ML, Kupelian PA, King CR. PMID: 28111115.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf? Cancer. 2017 02 01; 123(3):531-532. Kishan AU, Kupelian PA, Steinberg ML, King CR. PMID: 27997685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):516-525. Shaverdian N, Verruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR. PMID: 28126301.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer. Semin Respir Crit Care Med. 2016 10; 37(5):716-726. Kishan AU, Lee P. PMID: 27732993.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-60Co teletherapy device. Br J Radiol. 2016 Nov; 89(1067):20160624. Raghavan G, Kishan AU, Cao M, Chen AM. PMID: 27653787.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic. Ann Surg Oncol. 2016 12; 23(Suppl 5):634-641. Kishan AU, Gomez CL, Dawson NA, Dvorak R, Foster NM, Hoyt A, Hurvitz SA, Kusske A, Silver EL, Tseng C, McCloskey SA. PMID: 27619940.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 05; 71(5):766-773. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 27452951.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Having Your Cake and Eating It Too: Combining SBRT and Multi-agent Chemotherapy in Locally Advanced Pancreatic Cancer. Cureus. 2016 Jul 13; 8(7):e686. Kishan A, Lee P. PMID: 27555984.
      View in: PubMed   Mentions:
    74. Clinical Indicators of Psychosocial Distress Predict for Acute Radiation-Induced Fatigue in Patients Receiving Adjuvant Radiation Therapy for Breast Cancer: An Analysis of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):946-955. Kishan AU, Wang PC, Sharif J, Kupelian PA, Steinberg ML, McCloskey SA. PMID: 27105720.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    75. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer. Med Dosim. 2016; 41(1):87-91. Merna C, Rwigema JC, Cao M, Wang PC, Kishan AU, Michailian A, Lamb J, Sheng K, Agazaryan N, Low DA, Kupelian P, Steinberg ML, Lee P. PMID: 26755076.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    76. Lipids and Diabetic Retinopathy. Semin Ophthalmol. 2016; 31(1-2):10-8. Modjtahedi BS, Bose N, Papakostas TD, Morse L, Vavvas DG, Kishan AU. PMID: 26959124.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data. Ther Adv Med Oncol. 2016 Jan; 8(1):85-97. Kishan AU, McCloskey SA. PMID: 26753007.
      View in: PubMed   Mentions:
    78. In Regard to Bauman et al. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1162-3. Kishan AU, Steinberg ML, Kupelian PA, King CR. PMID: 26581152.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):268-75. Kishan AU, Wang PC, Upadhyaya SK, Hauswald H, Demanes DJ, Nickols NG, Kamrava M, Sadeghi A, Kupelian PA, Steinberg ML, Prionas ND, Buyyounouski MK, King CR. PMID: 26850649.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy. Br J Radiol. 2015; 88(1056):20150658. Kishan AU, Park SJ, King CR, Roberts K, Kupelian PA, Steinberg ML, Kamrava M. PMID: 26463234.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases. J Contemp Brachytherapy. 2015 Oct; 7(5):327-35. Kishan AU, Lee EW, McWilliams J, Lu D, Genshaft S, Motamedi K, Demanes DJ, Park SJ, Hagio MA, Wang PC, Kamrava M. PMID: 26622237.
      View in: PubMed   Mentions:
    82. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):366-73. Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P. PMID: 26432677.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):411-6. Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS. PMID: 26059510.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    84. Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):330-337. Kishan AU, Cao M, Wang PC, Mikaeilian AG, Tenn S, Rwigema JM, Sheng K, Low DA, Kupelian PA, Steinberg ML, Lee P. PMID: 25823383.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15; 91(4):832-9. Kishan AU, Lamb JM, Jani SS, Kang JJ, Steinberg ML, King CR. PMID: 25752398.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    86. Dosimetric feasibility of magnetic resonance imaging-guided tri-cobalt 60 preoperative intensity modulated radiation therapy for soft tissue sarcomas of the extremity. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):350-356. Kishan AU, Cao M, Mikaeilian AG, Low DA, Kupelian PA, Steinberg ML, Kamrava M. PMID: 25749215.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):173-8. Mesko S, Park SJ, Kishan AU, Demanes DJ, Kamrava M. PMID: 25537448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects. Brachytherapy. 2015 Mar-Apr; 14(2):148-59. Kishan AU, Kupelian PA. PMID: 25516492.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    89. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2015 Aug; 14(4):411-8. Kishan AU, Wang PC, Sheng K, Yu V, Ruan D, Cao M, Tenn S, Low DA, Lee P. PMID: 25261069.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    90. Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck. J Med Imaging Radiat Oncol. 2014 Oct; 58(5):618-24. Kishan AU, Cui J, Wang PC, Daly ME, Purdy JA, Chen AM. PMID: 24942938.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    91. Dose impact in radiographic lung injury following lung SBRT: Statistical analysis and geometric interpretation. Med Phys. 2014 Mar; 41(3):031701. Yu V, Kishan AU, Cao M, Low D, Lee P, Ruan D. PMID: 24593705.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    92. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell. 2012 Oct 16; 22(4):547-60. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H, Zhou F, Green MR, Chen L, Monti S, Marto JA, Shipp MA, Danial NN. PMID: 23079663.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    93. Radiation therapy for neovascular age-related macular degeneration. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):583-97. Kishan AU, Modjtahedi BS, Morse LS, Lee P. PMID: 22975610.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Radiotherapy is effective for a primary lung cancer invading the left atrium. BMJ Case Rep. 2012 Jul 19; 2012. Lee P, Kishan AU. PMID: 22814990.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    95. Shoulder pain and isolated brachial plexopathy. BMJ Case Rep. 2012 Jun 28; 2012. Kishan AU, Syed S, Fiorito-Torres F, Thakore-James M. PMID: 22744250.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Eyelash alopecia areata: case series and literature review. Can J Ophthalmol. 2012 Aug; 47(4):333-8. Modjtahedi BS, Kishan AU, Schwab IR, Jackson WB, Maibach HI. PMID: 22883840.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. Patterns of olivocochlear axonal branches. Open J Neurosci. 2011 Oct 12; 1. Kishan AU, Lee CC, Winer JA. PMID: 22348198.
      View in: PubMed   Mentions:
    98. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):172-178. Kishan AU, Chen MH, Loffredo M, Kim D, Beard CJ, Hurwitz MD, Martin NE, Orio PF, Kantoff PW, D'Amico AV, Nguyen PL. PMID: 24674120.
      View in: PubMed   Mentions:    Fields:    
    99. Wiring of divergent networks in the central auditory system. Front Neuroanat. 2011; 5:46. Lee CC, Kishan AU, Winer JA. PMID: 21847372.
      View in: PubMed   Mentions:
    100. Lipids and age-related macular degeneration. Surv Ophthalmol. 2011 May-Jun; 56(3):195-213. Kishan AU, Modjtahedi BS, Martins EN, Modjtahedi SP, Morse LS. PMID: 21439604.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    101. Branched projections in the auditory thalamocortical and corticocortical systems. Neuroscience. 2008 Jun 12; 154(1):283-93. Kishan AU, Lee CC, Winer JA. PMID: 18294776.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    102. Tension pneumocephalus following posterior fossa surgery in sitting position. A report of 2 cases. Clin Neurol Neurosurg. 1990; 92(3):245-8. Kishan A, Naidu MR, Muralidhar K. PMID: 2171832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Amar's Networks
    Concepts (271)
    Derived automatically from this person's publications.
    _
    Co-Authors (45)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _